Discovery of 2-aminothiazoles as potent antiprion compounds (Q33520644)

27 July 2017

title

Discovery of 2-aminothiazoles as potent antiprion compounds (English)

1 reference

27 July 2017

3

1 reference

27 July 2017

4

Stanley B Prusiner

1 reference

27 July 2017

Sina Ghaemmaghami

1

1 reference

27 July 2017

Barnaby C H May

series ordinal

2

1 reference

27 July 2017

publication date

23 December 2009

1 reference

27 July 2017

1 reference

27 July 2017

volume

84

1 reference

27 July 2017

issue

7

1 reference

27 July 2017

page(s)

3408-3412

1 reference

Direct and selective elimination of specific prions and amyloids by 4,5-dianilinophthalimide and analogs

27 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

Small-molecule aggregates inhibit amyloid polymerization

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

Cell division modulates prion accumulation in cultured cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

Library synthesis and screening: 2,4-diphenylthiazoles and 2,4-diphenyloxazoles as potential novel prion disease therapeutics

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

Structure-activity relationship study of prion inhibition by 2-aminopyridine-3,5-dicarbonitrile-based compounds: parallel synthesis, bioactivity, and in vitro pharmacokinetics

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (d

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

A systematic review of prion therapeutics in experimental models

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

JColorGrid: software for the visualization of biological measurements

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

Quinoline derivatives are therapeutic candidates for transmissible spongiform encephalopathies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

Shattuck lecture--neurodegenerative diseases and prions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

Prions causing degenerative neurological diseases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

Molecular biology of prion diseases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potential.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838138

CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20032192

12 December 2020

inferred from PubMed ID database lookup

Discovery and evaluation of N-cyclopropyl- 2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5- ylmethyl)amino)benzamide (BMS-605541), a selective and orally efficacious inhibitor of vascular endothelial growth factor receptor-2

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20032192

12 December 2020

inferred from PubMed ID database lookup

Identifiers

1 reference

https://api.fatcat.wiki/v0/release/kfwugz2oyverraeuceiu6glmgm

30 July 2022

release_kfwugz2oyverraeuceiu6glmgm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kfwugz2oyverraeuceiu6glmgm

30 July 2022

https://api.fatcat.wiki/v0/release/kfwugz2oyverraeuceiu6glmgm

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/kfwugz2oyverraeuceiu6glmgm

1 reference

30 July 2022